3509 results for «2029»
3509 results
Bridging the gap of oral P2Y12 inhibition for PCI with cangrelor: what does the new data tell us?
22 May 2019 – From EuroPCR 2019
Consult this session to learn through studies and clinical cases more about contemporary pharmacological strategies with intravenous antiplatelet therapy in PCI for STEMI, NSTEMI and complex stable coronary artery disease patients.
Thrombus horribilis
21 May 2019 – From EuroPCR 2019
Consult this session to discover a selection of compelling clinical cases regarding stent thrombosis and resulting in several complications. Watch it now to discover the treatment options!
Continuous LIVE demonstration from Hospital Universitario Clínico San Carlos - Madrid, Spain
21 May 2019
Left main bifurcation complicated cases: when planning and patience are paramount
22 May 2019 – From EuroPCR 2019
Consult this session to discover complicated left main bifurcation cases, and learn more about how to plan and select suitable stenting techniques for complex anatomies and how to better manage complications.
Myth busters – Truth or myth? Facts and data about renal denervation
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the fundamentals of radio-frequency ablation, the factors that may affect responders to renal denervation and the advancement of the renal denervation procedure.
Transcatheter tricuspid valve repair emerging evidence
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about transcatheter tricuspid valve repair latest evidence, and discover the results of TRIVALVE, TRI-REPAIR and STTAR studies.
Management of dislodged TAVI valves
22 May 2019 – From EuroPCR 2019
Consult this session to learn through various compelling clinical cases how to efficiently manage dislodged TAVI valves, and discover various tools and techniques to do so.
Abstracts from submissions - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to read 3 of the abstracts submitted for PCR Tokyo Valves 2020: thrombocytopenia after transfemoral TAVI, current generation transcatheter aortic valves in patients with large aortic annuli, and TAVI with Evolut R vs. Sapien 3 in small aortic annulus.
Troubleshooting transcatheter aortic valve implantation (TAVI) for common complications: my worst nightmare - Part 2
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about how to provide practical troubleshooting on transcatheter aortic valve implantation (TAVI) for common complications, such as annulus rupture, aortic rupture and ischemic stroke, and get insight into the pre-procedural planning to prevent these complications.
PCR Tokyo Valves 2020: Selection of the 2020 best clinical cases
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best clinical cases presented during PCR Tokyo Valves 2020: unusual cause of coronary artery obstruction after TAVI, simultaneous TAVR-in-TAVR and valve-in-mitral-annular-calcification intervention, paravalvular leak with valve-in-valve TAVR and bioprosthetic ring fracturing, and more!
Mitral and tricuspid valves: new technologies on the horizon
16 Feb 2020 – From PCR Tokyo Valves 2020
Learn about up-to-date data regarding new mitral and tricuspid percutaneous techniques and future repair technologies...
PCR Tokyo Valves 2020: Selection of the best abstracts
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of the best abstracts submitted at PCR Tokyo Valves 2020: the efficacy of direct visualization of MANTA using ultrasound-navigated technique following large-bore arteriotomy, inflammatory reaction associated with leaflet thrombosis in the transcatheter aortic valve, and more!
Imaging Day - Case-based echo imaging for the aortic valve
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about low-flow low-gradient aortic stenosis, and discover how to predict prothesis-patient mismatch and how to detect prosthetic valve thrombosis.
Opening Ceremony - Tokyo Valves 2020
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 opening ceremony, learn more about PCR's mission, charter, companions, and discover what makes this course unique.
Closing Ceremony - PCR Tokyo Valves 2020
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to see the slides of PCR Tokyo Valves 2020 closing ceremony, and discover who won the best clinical case and best abstract awards this year.
How should aortic stenosis be treated in the modern era and what is the role of the heart team?
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.
How to optimise coronary intervention therapy with SAPIEN 3
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Valve selection for patients with longer life
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.
TAVI as cutting edge
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about LOTUS Edge's current status, long term outcome in japan, and clinical use thanks to a selection of challenging cases.
